Advagene Biopharma Co., Ltd. (6709.TWO)
TWD 18.0
(-14.29%)
TWD 18.0
(-14.29%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -64.32 Million TWD | -316.59% |
| 2022 | -15.44 Million TWD | -55.43% |
| 2021 | -9.93 Million TWD | 91.41% |
| 2020 | -115.7 Million TWD | -840.66% |
| 2019 | -12.3 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -31.54 Million TWD | 50.96% |
| 2024 Q2 | -31.54 Million TWD | 1.05% |
| 2023 FY | -64.32 Million TWD | -316.59% |
| 2023 Q2 | -9.78 Million TWD | 14.25% |
| 2023 Q1 | -11.4 Million TWD | 26.11% |
| 2023 Q3 | -65.19 Million TWD | -566.37% |
| 2023 Q4 | -64.32 Million TWD | 1.33% |
| 2022 Q3 | -17.35 Million TWD | 0.0% |
| 2022 Q4 | -15.44 Million TWD | 11.03% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 16.514% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 75.652% |
| Level Biotechnology Inc. | -453.9 Million TWD | 85.829% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 46.653% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 67.249% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 112.868% |
| GlycoNex Incorporation | -148.56 Million TWD | 56.706% |
| VBI | -25.31 Million TWD | -154.073% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 259.74% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 146.611% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 75.504% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 310.351% |
| Visgeneer Inc. | 31.28 Million TWD | 305.604% |
| Mycenax Biotech Inc. | 207 Million TWD | 131.072% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 90.549% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 52.089% |
| Neith Corporation | -150.31 Million TWD | 57.208% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 110.349% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -11.556% |
| Enimmune corporation | -314.15 Million TWD | 79.526% |
| TaiRx, Inc. | -147.86 Million TWD | 56.501% |
| CHO Pharma, Inc. | -203.79 Million TWD | 68.438% |
| EirGenix Inc. | -4.58 Billion TWD | 98.598% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 24.117% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 153.215% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 98.001% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 79.736% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -224.64% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 302.21% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 226.728% |
| RBC Bioscience Corporation | 422.18 Million TWD | 115.235% |
| BiOptic Inc. | 12.59 Million TWD | 610.808% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 93.189% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 36.621% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 61.059% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 120.428% |
| NaviFUS Corp. | -123.12 Million TWD | 47.761% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 186.86% |
| Sinew Pharma Inc. | -160.34 Million TWD | 59.886% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 73.409% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 80.935% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 84.412% |
| AP Biosciences Inc | -196.52 Million TWD | 67.271% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 109.339% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -462.394% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 92.248% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 104.739% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 84.496% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 69.274% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 55.29% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 80.541% |
| TCI GENE Inc. | -689.25 Million TWD | 90.668% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 45.921% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 95.087% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 414.021% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 36.86% |
| PharmaEngine, Inc. | -860.8 Million TWD | 92.528% |
| Savior Lifetec Corporation | -812.54 Million TWD | 92.084% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 78.557% |
| OBI Pharma, Inc. | -398.22 Million TWD | 83.848% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 82.398% |
| Acepodia, Inc. | -6.02 Billion TWD | 98.932% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 98.109% |